Advertisement

Index by author

May 01, 2002; Volume 30,Issue 5

  1. Caudill, Douglas

    1. Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

  2. Crespi, Charles

    1. Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

  3. Desai, Pankaj B.

    1. Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

  4. Desta, Zeruesenay

    1. Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525

  5. Ding, Xinxin

    1. Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548

  6. Du, Bert N. La

    1. Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

  7. Edwards, Jeffrey E.

    1. Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

  8. Falany, Charles N.

    1. Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582

  9. Fang, Xiaojun

    1. Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

  10. Fitzpatrick, Jennifer L.

    1. Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570
« Previous (Pages : 1 2 3 4 5 6 7 ... 11) Next »
Back to top

In this issue

Advertisement